Molecular Docking Studies of Flavonoids of Noni Fruit (Morinda citrifolia L.) to Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ)

Supandi Supandi, Supandi dan Fikry, Awaluddin dan Andrianopsyah Mas, Jaya Putra Molecular Docking Studies of Flavonoids of Noni Fruit (Morinda citrifolia L.) to Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ). International Conference on Computation for Science and Technology. pp. 95-99.

[thumbnail of ICCST-2015.pdf]
Preview
Text
ICCST-2015.pdf

Download (1MB) | Preview

Abstract

Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the produced insulin. Morinda citrifolia has been widely used as herbal medicine to prevent and to treat diabetes as well as health supplements. It contains flavonoids which may act as an antidiabetic agent. One of the receptors that play a role in the treatment of diabetes is peroxisome proliferator-activated receptor - gamma (PPARγ) which responsible for insulin sensitization in adipose tissue. In this study, the interaction beetween flavonoids contained in noni fruit as ligands, and PPARγ was investigated by using the Autodock Vina software. Some flavonoids such as quercetin, kaempferol, nicotifloroside, narcissoside, and rutin were included in this study. Rosiglitazone, a known ligand for PPARγ was used as the standard. The result revealed that all the selected flavonoids showed binding energy ranging between –8,1 kcal/mol to –8,5 kcal/mol. Eventhough, when compared with rosiglitazone (–8.9 kcal/mol), the value of the binding energy of flavonoids was higher, but close to rosiglitazone. This suggests that those flavonoid compounds may show comparable potential with rosiglitazone as antidiabetic agent.

Item Type: Article
Subjects: R Medicine > RS Pharmacy and materia medica
Depositing User: admin repository uhamka
Date Deposited: 16 Oct 2018 03:25
Last Modified: 16 Oct 2018 03:25
URI: http://repository.uhamka.ac.id/id/eprint/576

Actions (login required)

View Item View Item